Drug
Ketotifen clinical trials
Also written Zaditen and Zaditor.
Includes 2 studies of Ketotifen fumarate ophthalmic solution.
- studies test it
- 23
- open now
- 4
- in phase 3
- 11
- first study started
- 2002
Keep track of what changes. Save the Ketotifen studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
22 studies that test it; most in 2022 (4)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 7
- Phase 3
- 11
- Phase 4
- 4
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 14
Bausch & Lomb Incorporated (5) · University of Calgary (2) · Tanta University (2) · Sen-Jam Pharmaceutical (1) · Senju USA, Inc. (1) · Johnson & Johnson Vision Care, Inc. (1) · Universitaire Ziekenhuizen KU Leuven (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1)
Often tested with
Tested in the same studies.
Naphazoline (2) · Vitamin E (1) · Brimonidine (1) · Indomethacin (1) · EM-100 (1) · Etafilcon A (1) · Desloratadine (1) · Aprepitant (1)
Studies
Open first, then newest update. How each study uses Ketotifen is read from its arms, and is right about nine times in ten.
Testing it · 23
- Mast Cell Treatment in Post-tick Bite Illness (PTBI)Not yet recruitingPhase 2University of North Carolina, Chapel HillNCT07526558Written as Ketotifen
- Topical Ketotifen 0.25% for Secondary VestibulodyniaRecruitingPhase 2Center for Vulvovaginal DisordersNCT07257029Written as Ketotifen Fumarate 0.25% Cream
- Ketotifen for Children With Functional Dyspepsia in Association With Duodenal EosinophiliaRecruitingPhase 3Craig A. Friesen, MDNCT02484248Written as Ketotifen
- The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral NeuropathyRecruitingPhase 3Tanta UniversityNCT05624138Written as Ketotifen Oral Tablet
- PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2CompletedPhase 3University of CalgaryNCT03582176Written as Ketotifen Fumarate 2mg
- Ketotifen in Non-Alcoholic Fatty Liver Disease PatientsCompletedPhase 4Tanta UniversityNCT05616442Written as Ketotifen
- Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic ConjunctivitisCompletedPhase 3Bausch & Lomb IncorporatedNCT05591755Written as Ketotifen fumarate ophthalmic solution 0.035%
- Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19CompletedPhase 3Sen-Jam PharmaceuticalNCT05007522Written as Ketotifen/Indomethacin
- Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.CompletedPhase 3Bausch & Lomb IncorporatedNCT00769886Written as Ketotifen/naphazoline
- Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic ConjunctivitisCompletedPhase 2Senju USA, Inc.NCT00836485Written as Ketotifen 4.0% Patch
- A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and VehicleCompletedPhase 3Bausch & Lomb IncorporatedNCT03489941Written as Zaditor®
- The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMIStatus unknownPhase 4Peking University Third HospitalNCT05511831Written as Ketotifen Fumarate
- Clinical Evaluation of Etafilcon A With KetotifenCompletedPhase 2Johnson & Johnson Vision Care, Inc.NCT03388138Written as etafilcon A with ketotifen
- Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.CompletedPhase 3Bausch & Lomb IncorporatedNCT00770133Written as Ketotifen/naphazoline
- Influence of Antipruritics on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.CompletedNot applicableUniversitaire Ziekenhuizen KU LeuvenNCT04399148Written as Ketotifen 1 MG
- Chronic Widespread Pain and White Blood Cell ActivationCompletedPhase 3McGill University Health Centre/Research Institute of the McGill University Health CentreNCT02984397Written as Ketotifen Fumarate
- Investigations of Mechanisms and Treatment in Post-traumatic Joint ContracturesCompletedPhase 2University of CalgaryNCT01902017Written as Ketotifen
- Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot StudyCompletedPhase 3Indiana UniversityNCT01553318Written as Ketotifen
- Ketotifen as a Treatment for Vascular Leakage During Dengue FeverStatus unknownPhase 4National University Hospital, SingaporeNCT02673840Written as Ketotifen
- A Study Of The Safety And Effectiveness Of A New Treatment For Allergic ConjunctivitisWithdrawnPhase 2Bausch & Lomb IncorporatedNCT00375596Written as Ketotifen/vasoconstrictor
See all 23 studies that test Ketotifen →
Given in every arm · 1 — Ketotifen is usual care beside what is tested
As the comparator · 4 — what is tested is compared with Ketotifen
- A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic DermatitisCompletedPhase 3Tanabe Pharma CorporationNCT01840605Written as ketotifen fumarate
- Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic ConjunctivitisCompletedPhase 3Bausch & Lomb IncorporatedNCT05579730Written as Ketotifen Fumarate 0.035%
- A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.CompletedPhase 3Faes Farma, S.A.NCT03479307Written as Ketotifen Ophthalmic Solution 0.025% (Zaditen)
- Cyclosporin A Eye Drop Treatment in Vernal KeratoconjunctivitisCompletedPhase 3Campus Bio-Medico UniversityNCT00426023Written as ketotifen fumarate 0.025% eye drops
Codes
What other systems call Ketotifen · ClinicalTrials.gg INT007713
- MeSH (NLM) D007665KetotifenConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) X49220T18GKETOTIFENConfirmed FDA, NLM, Wikidata
- RxNorm 6146Confirmed FDA, Wikidata
- Wikidata Q2458673ketotifenConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61799KetotifenOne source FDA
- DrugBank DB00920One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007665 | Ketotifen | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | X49220T18G | KETOTIFEN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6146 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2458673 | ketotifen | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61799 | Ketotifen | One source FDA |
| DrugBank | DB00920 | — | One source Wikidata |
Also registered as ketotifen fumarate (UNII HBD503WORO · RxNorm 11404).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.